# Combination of Oral Supplement With Fatty Acids, Vitamin B6, Perilla, and Liquorice With Nasal Steroids for the Treatment of Allergic Rhinitis

> **NCT07016763** · EARLY_PHASE1 · COMPLETED · sponsor: **Isola Tiberina - Gemelli Isola Hospital, Rome, Italy** · enrollment: 400 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DIETARY_SUPPLEMENT:** Oral fatty acid
- **DRUG:** Mometasone Furoate Nasal Spray (MFNS)

## Key facts

- **NCT ID:** NCT07016763
- **Lead sponsor:** Isola Tiberina - Gemelli Isola Hospital, Rome, Italy
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07016763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07016763, "Combination of Oral Supplement With Fatty Acids, Vitamin B6, Perilla, and Liquorice With Nasal Steroids for the Treatment of Allergic Rhinitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07016763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*